Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.

Sung Hye KongBo Kyung KooMin Kyong Moon

Published in: Diabetes & metabolism journal (2016)

In conclusion, the use of moderate-intensity statins reduced LDL-C levels less than 100 mg/dL in most of the Korean patients studied with T2DM. The efficacies of those statins were higher than expected in about 42% of Korean patients with T2DM.

Keyphrases

high intensity
cardiovascular disease
end stage renal disease
ejection fraction
chronic kidney disease
glycemic control
newly diagnosed
prognostic factors
peritoneal dialysis
adipose tissue
cardiovascular risk factors
patient reported